SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors are keenly focused on recent technical breakouts and the potential for S&P 500 inclusion, with many anticipating a pre-earnings rally. The community is actively debating the impact of recent capital raises and the upcoming stablecoin launch, alongside performance targets for the CEO. Bullish sentiment is countered by concerns over past share dilution and price volatility, though the broader fintech sector's momentum adds to the conversation.

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Alumis Inc.

Alumis Inc. is trending sharply upward following positive Phase 3 clinical trial results for its oral TYK2 inhibitor, envudeucitinib, in moderate-to-severe plaque psoriasis, showcasing exceptional skin clearance rates. The community is actively debating if these strong efficacy outcomes justify the significant market reaction, with some anticipating a classic biotech pump-and-dump while others view it as a high-potential long-term opportunity in the competitive immunology space.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending due to its strategic collaboration with OpenAI, enhancing its Athena AI marketing platform with advanced conversational intelligence, an announcement made at CES 2026. This news has ignited strong community discussion, with many anticipating a significant short squeeze given the stock's high short interest and perceived undervaluation. Investors are actively highlighting Zeta's position as a burgeoning leader in the AI-driven MarTech sector and its strengthening fundamentals.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to overwhelming short squeeze speculation, fueled by exorbitant borrow fees, limited share availability, and its inclusion on the Reg SHO list. The community is actively celebrating the stock sustaining above the critical $5 mark, which is seen as a gateway for institutional investment, and expressing high conviction in the groundbreaking potential of its GPS immunotherapy for AML. This confluence of factors, including promising clinical trial progress suggesting significantly extended patient survival, is driving intense discussion around a potential multi-billion dollar buyout and a significant re-rating of the company's value.

Memecoin on Injective taken over by the community.

Nonja

NONJA is trending as a top meme coin on the Injective blockchain, driven by its strong community actively discussing its leveraged performance against INJ and resilience during market downturns. The community highlights NONJA's organic growth, high burned liquidity, and successful NFT collections, positioning it for significant gains as Injective's ecosystem benefits from its robust fundamentals and upcoming ETF considerations.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently experiencing a significant surge in trading volume, driving strong bullish sentiment and community discussions predicting a notable price ascent. The conversation highlights its foundational technology in IoT and decentralized data, bolstered by Japanese regulatory compliance and anticipated 2026 ecosystem developments, with many viewing it as a long-term investment in a real technology project.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is generating significant buzz following announcements at CES 2026, most notably the integration of its 4D LiDAR as a reference sensor within the NVIDIA DRIVE Hyperion Platform ecosystem. The community is highly enthusiastic about this validation and Aeva's new Omni sensor for Physical AI applications, anticipating substantial stock appreciation driven by its low float and perceived technological leadership.

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.

Bright Minds Biosciences Inc

Bright Minds Biosciences is currently trending following positive Phase 2 clinical data for BMB-101, showing strong efficacy and a clean safety profile in treating drug-resistant epilepsy. This promising update has ignited intense community discussion, with many drawing parallels to prior explosive biotech surges and debating the potential for a significant short squeeze, while others express surprise at the market's reaction despite the scientific advancements.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending due to its pivotal role in the U.S. Department of Energy's Advanced Reactor Pilot Program, targeting an Integral Molten Salt Reactor pilot by July 2026, complemented by a recent Westinghouse contract for advanced nuclear fuel. The community is actively debating its significant undervaluation compared to peers like OKLO, highlighting its LEU fuel advantage and potential to power future AI data centers and industrial heat. Despite recent post-SPAC volatility, many investors view current levels as a key accumulation opportunity for this government-backed nuclear innovator.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as investors eagerly await a U.S. Department of Energy announcement on surplus plutonium fuel allocation, seen as critical for its advanced reactor development and the broader 'American Energy Dominance' push. The community is actively discussing the potential for 'fast-track' licensing for Small Modular Reactors and a significant short squeeze, driven by expectations that Oklo is poised to power the growing energy demands of AI data centers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Current Price	$48.41
Prev Close	$47.58
Open	$47.78
Dividend Yield	N/A
50-Day Moving Average	$47.70
Beta	N/A
Avg. Volume	32,148.09
PE Ratio	N/A

52-Week High	$50.54
52-Week Low	$36.74
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

NUMG
Nuveen Fund Advisors LLC - Nuveen ESG Mid-Cap Growth ETF

Feed

News

Sentiment

Fundamentals

Info

Latest NUMG News

NUMGNuveen Fund Advisors LLC - Nuveen ESG Mid-Cap Growth ETF